BackJohnson & Johnson Overview

Johnson & Johnson Current Assets

Track Johnson & Johnson's current assets ($60B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$59.77B
9.68% YoYΔ $5.28B vs prior year quarter

Peer trimmed avg / median

Loading

Johnson & Johnson Current Assets History

Loading

Johnson & Johnson vs. peers: Current Assets Comparison

Loading

Johnson & Johnson Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Johnson & Johnson (JNJ) FAQ

As of the most recent data (June 2026), JNJ shows a current assets of $60B. That compares with $54B in the prior-year period — up 9.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JNJ's current assets is now $60B (was $54B) — a 9.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Johnson & Johnson is outperforming or lagging.

Tracking JNJ's current assets over time shows whether Johnson & Johnson is scaling, shrinking, or reshaping that part of the business. The current reading is $60B That compares with $54B in the prior-year period — up 9.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $60B) with ownership activity and broader fundamentals.

Johnson & Johnson's current assets is $60B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.